EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Persistent sex disparities in access to dolutegravir‐based antiretroviral therapy in Latin America and the Caribbean: results from a retrospective observational study using data from 2017 to 2022

Fernanda F Fonseca iD, Paridhi Ranadive, Bryan E Shepherd, Flavia G F Ferreira, Maria F Rodríguez, Daisy M Machado, Vanessa Rouzier, Diana Varela, Fernanda Maruri, Peter Ribeiro iD, Beatriz Grinsztejn, Sandra Wagner Cardoso und 4 weitere

Journal of the International AIDS Society · 2025-07 · 28 (7)

DOI: 10.1002/jia2.26470 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the International AIDS Society, online erschienen am 09.07.2025. Verfasst von Fernanda F Fonseca und 15 weiteren Autor:innen. Beteiligte Einrichtung: AIDS Health Care Foundation, Global Program, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, Healthcare Disparities, Heterocyclic Compounds, 3-Ring, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNPq, FIC NIH HHS, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite its reversal in July 2019, the World Health Organization warning issued in May 2018 of potential teratogenicity associated with dolutegravir (DTG) may have produced persistent sex disparities in access to DTG. We compared DTG uptake of people with HIV (PWH) by sex in Latin America and the Caribbean (LAC) and its potential impact on virologic outcomes.

Methods

We evaluated DTG initiation among antiretroviral therapy (ART)‐naïve and ‐experienced cisgender PWH ≥16 years of age after DTG availability in Brazil (February/2017), Chile (August/2019), Haiti (November/2018) and Honduras (December/2018). Time was divided into pre‐ (before May/2018), during‐ (May/2018−July/2019) and post‐ (after July/2019) warning periods. We examined interactions of sex, age and calendar era with multivariable modified Poisson regression models and Cox proportional hazard models for the outcomes of DTG initiation among ART‐naïve and ART‐experienced PWH, respectively, and HIV RNA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Retroviral AgentsHealthcare DisparitiesHeterocyclic Compounds, 3-RingHIV InfectionsHIV Integrase InhibitorsOxazinesPiperazinesAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultCaribbean RegionHealth Services AccessibilityLatin AmericaPyridonesRetrospective StudiesSex FactorsDolutegravir

Stichwörter der Autor:innen

HIVdisparitiesdolutegravirgendersexwomen

Substanzen

Anti-Retroviral AgentsHeterocyclic Compounds, 3-RingHIV Integrase InhibitorsOxazinesPiperazinesPyridonesDolutegravir

Autor:innen und Institutionen

  • AIDS Health Care Foundation, Global Program, Sao Paulo, Brazil.
  • Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Departamento de Pediatria, UFMG, Faculdade de Medicina, Belo Horizonte, Brazil.
  • Hospital Clínico San Borja Arriarán, Fundación Arriarán, Santiago, Chile.
  • UNIFESP, Escola Paulista de Medicina, Disciplina de Infectologia Pediátrica, Sao Paulo, Brazil.

ORCID-Profile: Fernanda F Fonseca, Peter Ribeiro, Jessica L Castilho

Förderung

  • CNPq
  • FIC NIH HHS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fogarty International Center

Zitieren

APA

Fonseca, F. F., Ranadive, P., Shepherd, B. E., Ferreira, F. G. F., Rodríguez, M. F., Machado, D. M., Rouzier, V., Varela, D., Maruri, F., Ribeiro, P., Grinsztejn, B., Wagner Cardoso, S., Veloso, V. G., Castilho, J. L., Jalil, E. M., & CCASAnet (2025). Persistent sex disparities in access to dolutegravir‐based antiretroviral therapy in Latin America and the Caribbean: results from a retrospective observational study using data from 2017 to 2022. Journal of the International AIDS Society, 28(7). https://doi.org/10.1002/jia2.26470

Vancouver

Fonseca FF, Ranadive P, Shepherd BE, Ferreira FGF, Rodríguez MF, Machado DM, et al. Persistent sex disparities in access to dolutegravir‐based antiretroviral therapy in Latin America and the Caribbean: results from a retrospective observational study using data from 2017 to 2022. Journal of the International AIDS Society. 2025;28(7). doi:10.1002/jia2.26470

BibTeX
@article{Fonseca2025,
  author = {Fonseca, Fernanda F and Ranadive, Paridhi and Shepherd, Bryan E and Ferreira, Flavia G F and Rodríguez, Maria F and Machado, Daisy M and Rouzier, Vanessa and Varela, Diana and Maruri, Fernanda and Ribeiro, Peter and Grinsztejn, Beatriz and Wagner Cardoso, Sandra and Veloso, Valdiléa G and Castilho, Jessica L and Jalil, Emilia M and CCASAnet, CCASAnet},
  title = {Persistent sex disparities in access to dolutegravir‐based antiretroviral therapy in Latin America and the Caribbean: results from a retrospective observational study using data from 2017 to 2022},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  volume = {28},
  number = {7},
  doi = {10.1002/jia2.26470}
}
Kostenlos starten →